Serial #79087473
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79087473 Trademark

Serial Number: 79087473 • Registration: 4148282

Serial #79087473 is a trademark filed by BEIJING YUSHENGTANG INVESTMENT GROUP CO.,LTD on June 1, 2010. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

BEIJING YUSHENGTANG INVESTMENT GROUP CO.,LTD

18F, Tower A
Beijing , CN

Entity Type: 99

Trademark Details

Filing Date

June 1, 2010

Registration Date

May 29, 2012

Published for Opposition

March 13, 2012

Cancellation Date

June 1, 2020

Goods & Services

Tea; tea substitute; bee glue for human consumption; tea-based beverages; royal jelly for human consumption not for medicinal purposes; non-medicinal nutrition capsule in food preparation, namely, coffee capsules containing coffee for brewing; coffee; sweetmeats; bread; noodles; farinaceous food pastes for human consumption; ice cream; soya sauce; mutton seasoning; essences for foodstuffs except etheric essences and essential oils

Medicines for human purposes, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; pharmaceutical preparations for use in cytotoxic chemotherapy; dietetic foods adapted for medical use; tablets in round or oval shape, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; tablets in round or oval shape, namely, pharmaceutical preparations for use in cytotoxic chemotherapy; capsules for medicines, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; capsules for medicines, namely, pharmaceutical preparations for use in cytotoxic chemotherapy; pesticides; sanitary napkins; medicinal tea; pharmaceutical preparations for the treatment of teething; drugs for medical purposes, namely, pharmaceutical preparations for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; adhesive plaster for medical purposes; drug pillows, namely, sinus pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort and for reducing high blood pressure; Chinese medicine bags, namely, kits comprised of pharmaceutical preparations used for relief from headaches, insomnia and sinus discomfort; pharmaceutical preparations for treating hyperlipidemia, poor eyesight, cervical spondylosis, scapulohumeral periarthriti, chronic laryngotracheitis, and asthma; bateriostats for medical use; liquid antipruritic; pharmaceutical preparations for promoting blood circulation and to alleviate foot dropsy; Chinese medicine nostrum, namely, pharmaceuticals for treating respiratory illnesses, hematological illnesses, nervous system illnesses, thyroid illnesses, high white blood cells, anemia, hepatobiliary system illnesses, urinary system illnesses, infections, haemorrhoids, excessive gas, gout, digestive system illnesses, ophthalmology and otorhinolaryngology illnesses, menopause, gynecological illnesses, hair loss, immune system diseases, allergies, urinary tract illnesses, diabetes, cardiovascular illnesses, venereal diseases, liver diseases, and non-organ-specific rheumatological illnesses; antibiotic ointment; liquid pharmaceutical preparations used for dispelling mosquitoes, and curing eczema; and sterilising preparations

Medical clinics; medical massage; hospitals; health care; medical assistance; physiotherapy; dentistry; medical nursing; pharmacy advice, namely, pharmaceutical advice; dispensing of pharmaceuticals provided by pharmacists; food nutrition consulting; providing public bath facilities for hygiene purposes; rest homes; beauty salons

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 19, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 19, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 18, 2019 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Sep 16, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 16, 2019 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 4, 2019 INTR
CANCELLED SECTION 71
Jan 4, 2019 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2017 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 30, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 10, 2012 FICS
FINAL DISPOSITION PROCESSED
Oct 10, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2012 R.PR
NOTIFICATION PROCESSED BY IB
Apr 13, 2012 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 21, 2012 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 21, 2012 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2012 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 6, 2012 PREV
EXPARTE APPEAL TERMINATED
Feb 3, 2012 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2012 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 2, 2012 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 27, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 12, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 12, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 12, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 12, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 12, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 12, 2011 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2011 CRFA
ASSIGNED TO LIE
Dec 8, 2011 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 21, 2011 ERFR
EX PARTE APPEAL-INSTITUTED
Nov 21, 2011 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 21, 2011 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 21, 2011 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
May 20, 2011 GNFN
FINAL REFUSAL E-MAILED
May 20, 2011 GNFR
FINAL REFUSAL WRITTEN
May 20, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2011 TROA
REFUSAL PROCESSED BY IB
Nov 21, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2010 RFCS
REFUSAL PROCESSED BY MPU
Oct 29, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2010 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 26, 2010 MAFR
ASSIGNED TO EXAMINER
Oct 22, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 21, 2010 REPR